Design and characterization of HIV-1 vaccine candidates to elicit antibodies targeting multiple epitopes
Journal of Experimental Medicine · 2025
DOI: 10.1084/jem.20250693 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Experimental Medicine, 2025. Verfasst von Harry B Gristick und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA. Hauptthemen laut MEDLINE: AIDS Vaccines, HIV-1, Epitopes, HIV Antibodies. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Gates Foundation, NIH HHS.
Abstract (Originalsprache)
A primary goal in the development of an AIDS vaccine is the elicitation of broadly neutralizing antibodies (bNAbs) that protect against diverse HIV-1 strains. To this aim, germline-targeting immunogens have been developed to activate bNAb precursors and initiate the induction of bNAbs. While most preclinical germline-targeting HIV-1 vaccine candidates only include a single bNAb precursor epitope, an effective HIV-1 vaccine will likely require bNAbs that target multiple epitopes on Env. Here, we report a newly designed germline-targeting Env SOSIP trimer, named 3nv.2, that presents three bNAb epitopes on Env: the CD4bs, V3, and V2 epitopes. 3nv.2 forms a stable trimeric Env and binds to bNAb precursors from each of the desired epitopes. Immunization experiments in rhesus macaques and mice demonstrate 3nv.2 elicits the combined effects of its parent immunogens. Our results provide proof of concept for using a germline-targeting immunogen presenting three or more bNAb epitopes and a framework to develop improved next-generation HIV-1 vaccine candidates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA.
- Laboratory of Molecular Immunology, The Rockefeller University , New York, NY, USA.
- Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health , Bethesda, MD, USA.
- Howard Hughes Medical Institute, The Rockefeller University , New York, NY, USA.
ORCID-Profile: Harry B Gristick, Harald Hartweger, Yoshiaki Nishimura, Edem Gavor, Kaito Nagashima, Nicholas S Koranda, Priyanthi N P Gnanapragasam, Leesa M Kakutani, Luisa N Segovia, Olivia K Donau, Jennifer R Keeffe, Anthony P West, Malcolm A Martin, Michel C Nussenzweig, Pamela J Bjorkman
Förderung
- NIAID NIH HHS
- Gates Foundation
- NIH HHS
- National Institute of Allergy and Infectious Diseases
- Bill and Melinda Gates Foundation
- National Institutes of Health
Zitieren
APA
Gristick, H. B., Hartweger, H., Nishimura, Y., Gavor, E., Nagashima, K., Koranda, N. S., Gnanapragasam, P. N. P., Kakutani, L. M., Segovia, L. N., Donau, O. K., Keeffe, J. R., West, A. P., Martin, M. A., Nussenzweig, M. C., & Bjorkman, P. J. (2025). Design and characterization of HIV-1 vaccine candidates to elicit antibodies targeting multiple epitopes. Journal of Experimental Medicine. https://doi.org/10.1084/jem.20250693
Vancouver
Gristick HB, Hartweger H, Nishimura Y, Gavor E, Nagashima K, Koranda NS, et al. Design and characterization of HIV-1 vaccine candidates to elicit antibodies targeting multiple epitopes. Journal of Experimental Medicine. 2025. doi:10.1084/jem.20250693
BibTeX
@article{Gristick2025,
author = {Gristick, Harry B and Hartweger, Harald and Nishimura, Yoshiaki and Gavor, Edem and Nagashima, Kaito and Koranda, Nicholas S and Gnanapragasam, Priyanthi N P and Kakutani, Leesa M and Segovia, Luisa N and Donau, Olivia K and Keeffe, Jennifer R and West, Anthony P and Martin, Malcolm A and Nussenzweig, Michel C and Bjorkman, Pamela J},
title = {Design and characterization of HIV-1 vaccine candidates to elicit antibodies targeting multiple epitopes},
journal = {Journal of Experimental Medicine},
year = {2025},
doi = {10.1084/jem.20250693}
}
EUVIMED